Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-α-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor

European Journal of Immunology

Volumn 35, Issue 9, 2005, Pages 2699-2708

  Jin, Yixin ^a   Damaj, Bassam B ^a   Maghazachi, Azzam A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Chemotaxis; Lipids; Natural killer cells

Indexed keywords

ALPHA INTERFERON; CD16 ANTIGEN; CHEMOATTRACTANT; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; LYSOPHOSPHATIDYLCHOLINE; SPHINGOSYLPHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARTICLE; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFLAMMATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL CYCLE PROTEINS; CHEMOTAXIS; DITERPENES; FIBRINOLYTIC AGENTS; FLOW CYTOMETRY; GINKGOLIDES; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; KILLER CELLS, NATURAL; LACTONES; LYMPHOCYTE ACTIVATION; LYSOPHOSPHATIDYLCHOLINES; PERTUSSIS TOXIN; PHOSPHORYLCHOLINE; PLATELET ACTIVATING FACTOR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHINGOSINE;

EID: 23944520012     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526129     Document Type: Article

References (29)

1. Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J. and Damron, D. S., Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat. Cell Biol. 2000. 2: 261-265.
2. Murata, Y., Ogata, J., Higaki, Y., Kawashima, M., Yada, Y., Higuchi, K., Tsuchiya, T., Kawainami, S. and Imokawa, G., Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J. Invest. Deramatol. 1996. 106: 1242-1249.
3. Xu, Y., Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta 2002. 1582: 81-88.
4. Lusis, A. J., Atherosclerosis. Nature 2000. 407: 233-241.
5. Kabarowski, J. H., Zhu, K., Le, L. Q., Witte, O. N. and Xu, Y., Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 2001. 293: 702-705.
6. Witte, O. N., Kabarowski, J. H., Xu, Y., Le, L. Q. and Zhu, K., Retraction. Science 2005. 307: 206.
7. Kabarowki, J. H., Xu, Y. and Witte, O. N., Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 2002. 64: 161-167.
8. Coutant, F., Perrin-Cocon, L., Agaugue, S., Delair, T., Andre, P. and Lotteau, V., Mature dendritic cell generation promoted by lysophosphatidylcholine. J. Immunol. 2002. 169: 1688-1695.
9. Bussolati, B., Mariano, F., Cignetti, A., Guarini, A., Cambi, V., Foa, R., Piccoli, G. and Camussi, G., Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J. Immuol. 1998. 161: 1493-1500.
10. - human natural killer cells. Blood 2003. 102: 1569-1577.
11. Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R. et al., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003. 198: 1201-1212.
12. Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A. and Munz, C., The abundant NK cells in human secondary lymphoid tissue require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004. 172: 1455-1462.
13. Maghazachi, A. A., G protein-coupled receptors in natural killer cells. J. Leukoc. Biol. 2003. 74: 16-24.
14. Kveberg, L., Bryceson, Y., Inngjerdingen, M., Rolstad, B. and Maghazachi, A. A., Sphingosine-1-phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3-kinases. Eur. J. Immunol. 2002. 32: 1856-1864.
15. Jin, Y., Knudsen, E., Wang, L. and Maghazachi, A. A., Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization. Eur. J. Immunol. 2003. 33: 2083-2089.
16. Xu, Y. and Casey, G., Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14. Genomics 1996. 35: 397-402.
17. Huang, Y. H., Schafer-Elinder, L., Wu, R., Claesson, H.-E. and Frostegård, J., Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin. Exp. Immunol. 1999. 116: 326-331.
18. Nguyen, K. B., Salazar-Mather, T. P., Dalod, M. Y., Van Deusen, J. B., Wei, X.-q., Liew, F. Y., Caligiuri, M. A. et al., Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 2002. 169: 4279-4287.
19. Loza, M. J. and Perussia, B., Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat. Immunol. 2001. 2: 917-924.
20. Moretta, L., Bottino, C., Pende, D., Mingari, M. C., Biassoni, R. and Moretta, A., Human natural killer cells: their origin, receptors and function. Eur. J. Immunol. 2002. 32: 1205-1211.
21. Salazar-Mather, T. P., Lewis, C. A. and Biron, C.A., Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J. Clin. Invest. 2002. 110: 321-330.
22. Moretta, A., Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2002. 2: 957-964.
23. Glas, R., Franksson, L., Une, C., Eloranta, M.-L, Ohlen, C., Orn, A. and Karre K., Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: an adaptive component of NK cell-mediated responses. J. Exp. Med. 2000. 191: 129-138.
24. Granucci, F., Zanoni, I., Pavelka, N., van Dommelen, S. L., Andoniou, C. E., Belardelli, F., Degli-Esposti, M. A. and Ricciardi-Castagnoli, P., A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 2004. 200: 287-295.
25. Murphy, W. J., Tian, Z.-G., Asai, O., Funakoshi, S., Rotter, P., Henry, M., Strieter, R. M. et al., Chemokines and T lymphocyte activation. II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J. Immunol. 1996. 156: 2104-2111.
26. Maghazachi, A. A., Skålhegg, B. S., Rolstad, B. and Al-Aoukaty, A., Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 1997. 11: 765-774.
27. Mahalingam, S., Farber, J. M. and Karupiah, G., The interferon-inducible chemokine MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 1999. 73: 1479-1491.
28. Jin, Y., Knudsen, E., Wang, L., Bryceson, Y., Damaj, B., Gessani, S. and Maghazachi, A. A., Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 2003. 101: 4909-4915.
29. Inngjerdingen, M., Damaj, B. and Maghazachi, A. A., Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 2000. 164: 4048-4054.